Paula L. Miliani de Marval

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “The RP-Mdm2-p53 Pathway and Tumorigenesis”.

The RP-Mdm2-p53 Pathway and Tumorigenesis

UNC Libraries(2020)10.17615/rjy0-x015

N/A

0DataRank · unranked

0 citations

Yanping Zhang, Paula L. Miliani de Marval

Cdk2 Deficiency Decreases ras/CDK4-Dependent Malignant Progression, but Not myc-Induced Tumorigenesis

UNC Libraries(2020)10.17615/fvpv-yb05

N/A

0DataRank · unranked

0 citations

Andres J. Klein–Szanto, Marcelo L. Rodríguez‐Puebla, Paula L. Miliani de Marval, Yongbaek Kim, Everardo Macías

Deep Sequencing Shows Multiple Oligouridylations Are Required for 3′ to 5′ Degradation of Histone mRNAs on Polyribosomes

UNC Libraries(2020)10.17615/vpx2-af04

N/A

0DataRank · unranked

0 citations

Robert E. Rhoads, Stacie Meaux, Paula L. Miliani de Marval, Joshua D. Welch, Rebecca S. Bigler +4 more

Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development

UNC Libraries(2020)10.17615/h9ac-yp53

N/A

0DataRank · unranked

0 citations

Xian Wang, Paula L. Miliani de Marval, Christopher Sistrunk, Marcelo L. Rodríguez‐Puebla, Yongbaek Kim

Targeting YAP/TAZ-TEAD signaling as a therapeutic approach in head and neck squamous cell carcinoma

Cancer Letters(2025)10.1016/j.canlet.2025.217467

N/A

0DataRank · unranked

23 citations

Farhoud Faraji, Rodolfo Daniel Cervantes‐Villagrana, Xingyu Wu, Keiichi Koshizuka, Tomohiko Ishikawa +7 more